Clinical trial
Extracorporeal Shock Wave Therapy in the Treatment of Primary Dysmenorrhea:a Randomized Controlled-placebo Trial
NCT03121170 is registered in ClinicalTrials.gov with Ruirui Xing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extracorporeal Shock Wave Therapy in the Treatment of Primary Dysmenorrhea:a Randomized Controlled-placebo Trial
- Lead sponsor
- Ruirui Xing
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 4, 2017
- Completion date
- May 30, 2019
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dysmenorrhea primary, pain, menstrual